<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1157" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1157/" /><meta name="ncbi_pagename" content="Epidermolysis Bullosa with Pyloric Atresia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Epidermolysis Bullosa with Pyloric Atresia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Epidermolysis Bullosa with Pyloric Atresia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/09/07" /><meta name="citation_author" content="Ellen G Pfendner" /><meta name="citation_author" content="Anne W Lucky" /><meta name="citation_pmid" content="20301336" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1157/" /><meta name="citation_keywords" content="Carmi Syndrome" /><meta name="citation_keywords" content="EB-PA" /><meta name="citation_keywords" content="Junctional Epidermolysis Bullosa with Pyloric Atresia" /><meta name="citation_keywords" content="PA-JEB" /><meta name="citation_keywords" content="Carmi Syndrome" /><meta name="citation_keywords" content="EB-PA" /><meta name="citation_keywords" content="Junctional Epidermolysis Bullosa with Pyloric Atresia" /><meta name="citation_keywords" content="PA-JEB" /><meta name="citation_keywords" content="Integrin alpha-6" /><meta name="citation_keywords" content="Integrin beta-4" /><meta name="citation_keywords" content="Plectin" /><meta name="citation_keywords" content="ITGA6" /><meta name="citation_keywords" content="ITGB4" /><meta name="citation_keywords" content="PLEC" /><meta name="citation_keywords" content="Epidermolysis Bullosa with Pyloric Atresia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Epidermolysis Bullosa with Pyloric Atresia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ellen G Pfendner" /><meta name="DC.Contributor" content="Anne W Lucky" /><meta name="DC.Date" content="2017/09/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1157/" /><meta name="description" content="Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy." /><meta name="og:title" content="Epidermolysis Bullosa with Pyloric Atresia" /><meta name="og:type" content="book" /><meta name="og:description" content="Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1157/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/eb-pa/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1157/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D429EE04110610000000000B1004A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1157_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1157_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ebs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gale-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1157_"><span class="title" itemprop="name">Epidermolysis Bullosa with Pyloric Atresia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Carmi Syndrome, EB-PA, Junctional Epidermolysis Bullosa with Pyloric Atresia, PA-JEB</div><p class="contrib-group"><span itemprop="author">Ellen G Pfendner</span>, PhD and <span itemprop="author">Anne W Lucky</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1157_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1157_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ellen G Pfendner</span>, PhD<div class="affiliation small">Director, EBDx Program<br />GeneDx, Inc<br />Gaithersburg, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.xdeneg@nelle" class="oemail">moc.xdeneg@nelle</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anne W Lucky</span>, MD<div class="affiliation small">Director, Cincinnati Children's Epidermolysis Bullosa Center<br />Cincinnati Children's Hospital<br />Cincinnati, Ohio</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 22, 2008</span>; Last Update: <span itemprop="dateModified">September 7, 2017</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="eb-pa.Summary" itemprop="description"><h2 id="_eb-pa_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of EB-PA is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical findings by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> that identifies <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes associated with EB-PA: <i>ITGA6</i> (~5% of EB-PA), <i>ITGB4</i> (~80%), or <i>PLEC</i> (~15%). Skin biopsy using transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping can be performed but is no longer the preferred method of diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Lance and drain new blisters and dress with three layers (primary: nonadherent; secondary: for stability and protection; tertiary: elastic properties to insure integrity); protect skin from shearing forces; teach caretakers proper handling of infants and children; surgical intervention to correct pyloric atresia; standard treatment for gastroesophageal reflux disease; nutrition consultation to address oral intake and nutritional needs; referral to urology and/or nephrology for renal anomalies and abnormal renal function; tracheostomy when indicated for respiratory failure; psychosocial support, including social services and psychological counseling.</p><p><i>Prevention of primary manifestations:</i> Minimization of new blister formation by wrapping and padding of extremities, use of soft and properly fitted clothing and footwear, avoidance of contact with adhesives and of contact sports and other activities that create friction.</p><p><i>Prevention of secondary complications:</i> Antibiotics and antiseptics to prevent wound infections; attention to fluid and electrolyte balance; additional nutritional support including a feeding gastrostomy when necessary; calcium, vitamin D, zinc, selenium, carnitine, and iron supplements as indicated.</p><p><i>Surveillance:</i> Annual screening for anemia and zinc, vitamin D, and other nutritional deficiencies; periodic echocardiographic screening for dilated cardiomyopathy; bone mineral density scanning for detection of osteopenia and/or osteoporosis.</p><p><i>Agents/circumstances to avoid:</i> Shearing forces on the skin; ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>; poorly fitting or coarse-textured clothing and footwear.</p><p><i>Pregnancy management:</i> Consider cesarean section to reduce trauma to the skin of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus during delivery.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>EB-PA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are usually obligate heterozygotes (i.e., carriers). Because <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> and uniparental isodisomy are possible, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of parents needs to be confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. At conception, each sib of an affected individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for family members at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> or <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for pregnancies at increased risk are possible if both pathogenic variants have been identified in the family.</p></div></div><div id="eb-pa.Diagnosis"><h2 id="_eb-pa_Diagnosis_">Diagnosis</h2><div id="eb-pa.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Epidermolysis bullosa with pyloric atresia (EB-PA) <b>should be suspected</b> in newborns with the following clinical features:</p><ul><li class="half_rhythm"><div>Congenital pyloric atresia with vomiting and abdominal distension resulting from complete obstruction of the gastric outlet. Radiographs reveal that the stomach is distended and filled with air (see <a class="figpopup" href="/books/NBK1157/figure/eb-pa.F1/?report=objectonly" target="object" rid-figpopup="figebpaF1" rid-ob="figobebpaF1">Figure 1</a>).</div></li><li class="half_rhythm"><div>Fragility of the skin with:</div><ul><li class="half_rhythm"><div>Blistering with little or no trauma. Blistering may be mild or severe; however, blisters generally heal with no significant scarring.</div></li><li class="half_rhythm"><div>Significant oral and mucous membrane involvement</div></li><li class="half_rhythm"><div>Large areas of absent skin (aplasia cutis <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>), often with a thin membranous covering, affecting the extremities or head</div></li></ul></li><li class="half_rhythm"><div>Ureteral and renal anomalies, including hydronephrosis, ureterocele, absent bladder, dysplastic kidneys, urinary collecting system/kidney duplication, obstructive uropathy, and glomerulosclerosis</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figebpaF1" co-legend-rid="figlgndebpaF1"><a href="/books/NBK1157/figure/eb-pa.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figebpaF1" rid-ob="figobebpaF1"><img class="small-thumb" src="/books/NBK1157/bin/eb-pa-Image001.gif" src-large="/books/NBK1157/bin/eb-pa-Image001.jpg" alt="Figure 1. . Radiograph of a 36-week gestational-age, one-day-old neonate with EB-PA." /></a><div class="icnblk_cntnt" id="figlgndebpaF1"><h4 id="eb-pa.F1"><a href="/books/NBK1157/figure/eb-pa.F1/?report=objectonly" target="object" rid-ob="figobebpaF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Radiograph of a 36-week gestational-age, one-day-old neonate with EB-PA. Note the single gastric bubble (white arrow). </p></div></div></div><div id="eb-pa.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of EB-PA <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by one or both of the following:</p><ul><li class="half_rhythm"><div>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with EB-PA using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK1157/table/eb-pa.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figebpaTmoleculargenetictestingusedi" rid-ob="figobebpaTmoleculargenetictestingusedi">Table 1</a>)</div></li><li class="half_rhythm"><div>Skin biopsy using transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping (see <a href="#eb-pa.Skin_Biopsy">Skin Biopsy</a>)</div></li></ul><p>Note: Genetic testing is the preferred diagnostic method. Skin biopsy for diagnostic purposes is no longer routinely performed</p><div id="eb-pa.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Molecular testing approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>, and <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> (including <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis) that includes <i>ITGA6, ITGB4</i>, <i>PLEC</i>, and other genes of interest (see <a href="#eb-pa.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying phenotype. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused exome analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may also be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b></p><ul><li class="half_rhythm"><div>Sequence analysis of <i>ITGB4</i> may be performed first, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div>If only one no or <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ITGB4</i> is identified, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>PLEC</i> followed by <i>ITGA6</i> (if only one or no pathogenic variant in <i>PLEC</i> is identified) may be considered next.</div></li></ul><div id="eb-pa.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Epidermolysis Bullosa with Pyloric Atresia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1157/table/eb-pa.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eb-pa.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of EP-BA Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ITGA6</i></td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr><tr><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ITGB4</i></td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60%</td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~98%&#x000a0;<sup>6</sup></td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLEC</i></td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%</td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%</td><td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="eb-pa.TF.1.1"><p class="no_margin">See <a href="/books/NBK1157/#eb-pa.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="eb-pa.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al [2006]</a></p></div></dd><dt>3. </dt><dd><div id="eb-pa.TF.1.3"><p class="no_margin">See <a href="#eb-pa.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="eb-pa.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="eb-pa.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="eb-pa.TF.1.6"><p class="no_margin">50% of persons of Hispanic heritage in the United States have the <i>ITGB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1157/table/eb-pa.T.selected_itgb4_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figebpaTselecteditgb4pathogenicvarian" rid-ob="figobebpaTselecteditgb4pathogenicvarian">p.Cys61Tyr</a> [<a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>].</p></div></dd><dt>7. </dt><dd><div id="eb-pa.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#eb-pa.REF.birnbaum.2008.1063">Birnbaum et al [2008]</a>, <a class="bk_pop" href="#eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al [2016]</a></p></div></dd></dl></div></div></div></div><div id="eb-pa.Skin_Biopsy"><h4>Skin Biopsy</h4><p>Examination of a skin biopsy by (1) transmission electron microscopy (TEM) and/or (2) immunofluorescent antibody/antigen mapping is sometimes performed to establish the diagnosis of EB-PA</p><p>A punch biopsy that includes the full basement membrane zone is preferred. The biopsy should be taken from the leading edge of a fresh (&#x0003c;12 hours old) blister or from a mechanically induced blister (with a pencil eraser rubbed on the skin). (Older blisters undergo change that may obscure the diagnostic morphology).</p><p>Note:</p><ul><li class="half_rhythm"><div><b>For TEM</b></div><ul><li class="half_rhythm"><div>Specimens must be placed in special fixation medium (e.g., gluteraldehyde) as designated by the laboratory performing the test.</div></li><li class="half_rhythm"><div>Formaldehyde-fixed samples cannot be used for electron microscopy.</div></li></ul></li><li class="half_rhythm"><div><b>For immunofluorescent antibody/antigen mapping</b></div><ul><li class="half_rhythm"><div>Specimens should be sent in sterile carrying medium (e.g., Michel's or Zeus&#x02019;) as specified by the laboratory performing the test.</div></li><li class="half_rhythm"><div>Some laboratories prefer flash-frozen tissue.</div></li><li class="half_rhythm"><div>In some laboratories the mapping only designates the level of the cleavage by using various marker antibodies of different layers of the basement membrane. A laboratory that has the antigens for the proteins of interest in EB is preferred because both the level of cleavage and the presence or absence of the specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> products mutated in EB can be assessed.</div></li></ul></li><li class="half_rhythm"><div><b>Light microscopy</b> is inadequate and unacceptable for the accurate diagnosis of any subtypes of EB.</div></li></ul><p><b>Transmission electron microscopy (TEM)</b> is used to examine the number and morphology of the basement membrane zone structures &#x02013; in particular: the number and morphology of anchoring fibrils; the presence of and morphology of hemidesmosomes, anchoring filaments, and keratin intermediate filaments; and the presence of micro-vesicles showing the tissue cleavage plane.</p><p>Findings on TEM in EB-PA include the following:</p><ul><li class="half_rhythm"><div>Cleavage may be within the lamina lucida or just above the hemidesmosomes in the lowest layer of the basal keratinocytes.</div></li><li class="half_rhythm"><div>Hemidesmosomes may be reduced in number or <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> [<a class="bk_pop" href="#eb-pa.REF.kunz.2000.376">Kunz et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.jonkman.2002.1275">Jonkman et al 2002</a>, <a class="bk_pop" href="#eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</a>, <a class="bk_pop" href="#eb-pa.REF.pasmooij.2004.669">Pasmooij et al 2004</a>].</div></li></ul><p><b>Immunofluorescent antibody/antigen mapping.</b> Findings include the following:</p><ul><li class="half_rhythm"><div>Abnormal or absent staining with antibodies to &#x003b1;6&#x003b2;4 integrin in EB-PA and other rare forms of junctional epidermolysis bullosa (JEB) as a result of pathogenic variants in either <i>ITGA6</i> or <i>ITGB4</i></div></li><li class="half_rhythm"><div>Abnormal or absent staining with antibodies to plectin in EB-PA as a result of <i>PLEC</i> pathogenic variants</div></li></ul><p>Normal staining for other antigens (e.g., collagen VII, laminin 332, keratins 5 and 14) confirms the diagnosis of EB-PA.</p><p>Note: Especially in milder forms of EB, indirect immunofluorescent studies are often not sufficient to make the diagnosis because near-normal antigen levels are detected and no cleavage plane is observed. In addition, absence of one hemidesmosomal component (e.g., ITGA6 or ITGB4) may reduce the staining of other hemidesmosomal components as well (e.g., PLEC, COL17). In these cases electron microscopic examination of a skin biopsy must be performed.</p></div></div></div><div id="eb-pa.Clinical_Characteristics"><h2 id="_eb-pa_Clinical_Characteristics_">Clinical Characteristics</h2><div id="eb-pa.Clinical_Description"><h3>Clinical Description</h3><p>The course of epidermolysis bullosa with pyloric atresia (EB-PA) is usually severe and often lethal in the neonatal period. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children succumb as neonates.</p><p><b>Cutaneous manifestations.</b> Those who survive the neonatal period may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have little or no blistering later in life. Many of the findings listed below are present in multiple forms of EB and are not diagnostic of EB-PA.</p><ul><li class="half_rhythm"><div><b>Congenital localized absence of skin (aplasia cutis congenita)</b> can be seen in any of the major types of EB and is not a discriminating diagnostic feature of any of these types of EB. Infants with extensive aplasia cutis congenita and blistering or erosions may have fatal infections with sepsis and severe electrolyte imbalance in the first weeks to months of life.</div></li><li class="half_rhythm"><div><b>Milia</b> are small white-topped papules; they are often confused with epidermal cysts.</div></li><li class="half_rhythm"><div><b>Nail dystrophy</b> is defined as changes in size, color, shape, or texture of nails.</div></li><li class="half_rhythm"><div><b>Scarring alopecia</b> is defined as complete loss of scalp hair follicles as a result of scarring and loss of hair follicles.</div></li><li class="half_rhythm"><div><b>Hypotrichosis</b> is defined as reduction in the number of hair follicles in a given area compared to the number of hair follicles in the same area of a normal individual of the same gender.</div></li><li class="half_rhythm"><div><b>Exuberant granulation tissue</b> does not usually appear until the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child is a few years old and most children with EB-PA do not survive that long.</div></li><li class="half_rhythm"><div><b>Contractures</b> may result from loss of mobility of joints as a result of fibrous tissue scars.</div></li></ul><p><b>Pyloric atresia</b> may be detected in utero using ultrasound or MRI (see Genetic Counseling, <a href="#eb-pa.Prenatal_Testing_and_Preimplantati">Prenatal Testing and Preimplantation Genetic Diagnosis</a>). Pyloric atresia is evident at birth. It is characterized by vomiting, failure to tolerate any feeding or to pass stool, and a distended abdomen with a large stomach bubble (see <a class="figpopup" href="/books/NBK1157/figure/eb-pa.F1/?report=objectonly" target="object" rid-figpopup="figebpaF1" rid-ob="figobebpaF1">Figure 1</a>). Surgical repair of the pyloric atresia is necessary for survival.</p><p><b>Renal and ureteral anomalies</b> can include dysplastic/multicystic kidney, hydronephrosis/hydroureter, acute renal tubular necrosis, obstructive uropathy, ureterocele, duplicated renal collecting system, and absent bladder [<a class="bk_pop" href="#eb-pa.REF.puvabanditsin.1997.359">Puvabanditsin et al 1997</a>, <a class="bk_pop" href="#eb-pa.REF.kambham.2000.190">Kambham et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.nakano.2000.493">Nakano et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.wallerstein.2000.286">Wallerstein et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>, <a class="bk_pop" href="#eb-pa.REF.pfendner.2007.781">Pfendner et al 2007</a>, <a class="bk_pop" href="#eb-pa.REF.walker.2017.e61">Walker et al 2017</a>].</p></div><div id="eb-pa.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The forms of EB-PA with the severest cutaneous manifestations are caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on each <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that results in a premature termination codon, although a number of amino acid substitutions also result in a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, such as the recurrent <i>ITGB4</i> variant <a class="figpopup" href="/books/NBK1157/table/eb-pa.T.selected_itgb4_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figebpaTselecteditgb4pathogenicvarian" rid-ob="figobebpaTselecteditgb4pathogenicvarian">p.Cys61Tyr</a>, which is common in Hispanic individuals with EB-PA [<a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>, <a class="bk_pop" href="#eb-pa.REF.masunaga.2015.61">Masunaga et al 2015</a>, <a class="bk_pop" href="#eb-pa.REF.mutlu.2015.385">Mutlu et al 2015</a>, <a class="bk_pop" href="#eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al 2016</a>, <a class="bk_pop" href="#eb-pa.REF.masunaga.2017.160">Masunaga et al 2017</a>].</p></div><div id="eb-pa.Penetrance"><h3>Penetrance</h3><p>Pathogenic variants in <i>ITGA6</i>, <i>ITGB4</i>, and <i>PLEC</i> are 100% penetrant in individuals who have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div><div id="eb-pa.Prevalence"><h3>Prevalence</h3><p>According to the National EB Registry, prevalence of all types of junctional epidermolysis bullosa (JEB) is 0.44 per million in the US population [<a class="bk_pop" href="#eb-pa.REF.fine.1999">Fine et al 1999</a>]. Historically, EB-PA was considered a subclass of junctional EB (JEB); however, EB-PA is rare and its prevalence and incidence have not been determined.</p><p>Since EB-PA is extremely rare, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency in the general population is not known; however, it can be conservatively estimated at less than one in 5000 (~10x rarer than Herlitz junctional epidermolysis bullosa [HJEB], the carrier frequency of which is ~1:700).</p></div></div><div id="eb-pa.Genetically_Related_Allelic_Disord"><h2 id="_eb-pa_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b><i>ITGA6</i>.</b> EB-PA is the only <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with pathogenic variants in <i>ITGA6</i>.</p><p><b><i>ITGB4</i>.</b> Biallelic pathogenic variants in <i>ITGB4</i> rarely cause <a href="/books/n/gene/ebs/">epidermolysis bullosa simplex</a> (EBS), <a href="/books/n/gene/ebj/">junctional epidermolysis bullosa</a> (JEB) [<a class="bk_pop" href="#eb-pa.REF.inoue.2000.1061">Inoue et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.jonkman.2000.227">Jonkman et al 2000</a>], or pyloric atresia with desquamative enteropathy and no skin disease [<a class="bk_pop" href="#eb-pa.REF.salvestrini.2008.585">Salvestrini et al 2008</a>].</p><p><b><i>PLEC</i>.</b> The other phenotypes associated with <i>PLEC</i> pathogenic variants:</p><ul><li class="half_rhythm"><div><b>EB with muscular dystrophy (EB-MD)</b> (OMIM <a href="http://www.omim.org/entry/226670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">226670</a>) [<a class="bk_pop" href="#eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</a>, <a class="bk_pop" href="#eb-pa.REF.kossharnes.2004.124">Koss-Harnes et al 2004</a>, <a class="bk_pop" href="#eb-pa.REF.schara.2004.218">Schara et al 2004</a>, <a class="bk_pop" href="#eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</a>]. Approximately 50 cases of EB-MD have been reported worldwide. Blistering occurs early and is generally mild. Muscular dystrophy may not appear until later childhood, adolescence, or in some cases adulthood, and can cause immobility and eventually death later in life. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop cardiomyopathy [<a class="bk_pop" href="#eb-pa.REF.villa.2015.165">Villa et al 2015</a>]. Pathogenic variants have been described throughout <i>PLEC</i> but appear to cluster in the two long open reading frames containing exons in the 3' end of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Nonsense, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, and splice junction variants have been described. The mildest phenotypes are usually associated with <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> insertions or deletions, which do not alter the reading frame of the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> [<a class="bk_pop" href="#eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><b>Limb-girdle muscular dystrophy type 2Q</b> (OMIM <a href="http://omim.org/entry/613723" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613723</a>). This condition has been described in three Turkish families. Clinical features include proximal muscle weakness with onset in childhood and progression in puberty. Affected individuals were not reported to have any skin findings. The condition is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a pathogenic 9-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in the alternately spliced and expressed exon1 (f) of plectin, which may be related to the expression of this isoform in different tissues [<a class="bk_pop" href="#eb-pa.REF.gundesli.2010.834">Gundesli et al 2010</a>].</div></li><li class="half_rhythm"><div><b>EB</b>
<b>simplex</b><b>-Ogna</b> (see <a href="/books/n/gene/ebs/">Epidermolysis Bullosa Simplex</a>), observed in one Norwegian and one German family with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, is a result of the site-specific <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> p.Arg2110Trp variant within the rod <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of <i>PLEC</i> [<a class="bk_pop" href="#eb-pa.REF.kossharnes.2002.87">Koss-Harnes et al 2002</a>]. A single lethal case of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> EBS resulting from <i>PLEC</i> pathogenic variants has also been described [<a class="bk_pop" href="#eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</a>]. <a class="bk_pop" href="#eb-pa.REF.kunz.2000.376">Kunz et al [2000]</a> also described a case of EBS with severe mucous membrane involvement as a result of pathogenic variants in <i>PLEC</i>.</div></li></ul></div><div id="eb-pa.Differential_Diagnosis"><h2 id="_eb-pa_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Pyloric atresia.</b> In contrast to pyloric stenosis, which presents insidiously with vomiting, pyloric atresia is present at birth and causes complete obstruction of the gastric outlet. The diagnosis of epidermolysis bullosa with pyloric atresia (EB-PA) should be considered in every neonate with pyloric atresia regardless of the degree of skin blistering.</p><p><b>Epidermolysis bullosa (EB).</b> According to the 2014 classification system, the four major types of EB, caused by pathogenic variants in 18 different genes, are EB <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (EBS), junctional EB (JEB), dystrophic EB (DEB), and Kindler syndrome (KS) [<a class="bk_pop" href="#eb-pa.REF.fine.2014.1103">Fine et al 2014</a>]. Classification into major type is based on the location of blistering in relation to the dermal-epidermal junction of skin. Subtypes are predominantly determined by clinical features and supported by molecular diagnosis.</p><p>The four major types of EB share easy fragility of the skin (and mucosa in many cases), manifested by blistering with little or no trauma. Although clinical examination is useful in determining the extent of blistering and the presence of oral and other mucous membrane lesions, defining characteristics such as the presence and extent of scarring &#x02013; especially in young children and neonates &#x02012; may not be established or significant enough to allow identification of EB type; thus, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (or less commonly skin biopsy) is usually required to establish the most precise diagnosis. The ability to induce blisters with friction (although the amount of friction can vary) and to enlarge blisters by applying pressure to the blister edge is common to all; mucosal and nail involvement and the presence or absence of milia may not be helpful discriminators.</p><p>Post-inflammatory changes, such as those seen in generalized severe EBS (EBS-gen sev), are often mistaken for scarring or mottled pigmentation. Scarring can occur in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and junctional EB as a result of infection of erosions or scratching, which further damages the exposed surface. Congenital absence of the skin can be seen in any of the four major types of EB and is not a discriminating diagnostic feature.</p><p>Corneal erosions, esophageal strictures, and nail involvement may indicate either DEB or JEB. In milder cases, scarring (especially of the dorsal hands and feet) suggests DEB. Pseudosyndactyly (mitten deformities) resulting from scarring of the hands and feet in older children and adults usually suggests DEB.</p><p><a href="/books/n/gene/ebs/"><b>Epidermolysis bullosa simplex</b></a>
<b>(EBS)</b> is characterized by fragility of the skin that results in nonscarring blisters caused by little or no trauma. The four most common clinical subtypes of EBS range from relatively mild blistering of the hands and feet to more generalized blistering, which can be fatal. Although EB-PA caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic changes in <i>PLEC</i> is classified as a form of EBS, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are very rare compared to the overwhelming majority of individuals with EB caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (or rarely biallelic) pathogenic variants in <i>KRT5</i> or <i>KRT14</i>, which encode keratin 5 or 14, respectively. Therefore, the 2014 nomenclature refers to the specific pathogenic variants found in <i>KRT5</i> or <i>KRT14</i> (see <a href="/books/n/gene/ebs/#ebs.Nomenclature">EBS: Nomenclature</a>).</p><ul><li class="half_rhythm"><div>In <b>EBS, localized</b> (EBS-loc; previously known as Weber-Cockayne type), blisters are rarely present at birth and may occur on the knees and shins with crawling or on the feet at approximately age 18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant.</div></li><li class="half_rhythm"><div>In <b>EBS, generalized intermediate</b> (<b>EBS-gen intermed</b>; previously known as Koebner type), blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-gen sev.</div></li><li class="half_rhythm"><div>In <b>EBS with mottled pigmentation type (EBS-MP)</b>, skin fragility is evident at birth and clinically indistinguishable from EBS-gen sev; over time, progressive brown pigmentation interspersed with depigmented spots develops on the trunk and extremities, the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur.</div></li><li class="half_rhythm"><div>In <b>EBS, generalized severe</b> (<b>EBS-gen sev</b>; previously known as Dowling-Meara type), onset is usually at birth; severity varies greatly, both within and among families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in adult life. Nail dystrophy and milia are common. Both hyperpigmentation and hypopigmentation can occur. Mucosal involvement in EBS-gen sev may interfere with feeding. Blistering can be severe enough to result in neonatal or infant death.</div></li></ul><p><b>EB caused by pathogenic variants in <i>PLEC</i>.</b> Biallelic and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>PLEC</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding plectin, which is located in the hemidesmosomes of the basement membrane zone of skin and muscle cells, cause cleavage in the basal keratinocyte layer. Hence, these disorders are classified as EBS in the 2014 classification system. In most cases, the associated phenotypes (i.e., EB with muscular dystrophy, EB with pyloric atresia) are more complex:</p><ul><li class="half_rhythm"><div><b>EB with muscular dystrophy (EB-MD).</b> See <a href="#eb-pa.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>.</div></li><li class="half_rhythm"><div><b>EB with pyloric atresia (EB-PA)</b> See <a href="#eb-pa.Clinical_Characteristics">Clinical Characteristics</a>.</div></li><li class="half_rhythm"><div><b>EB-Ogna.</b> See <a href="#eb-pa.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>.</div></li></ul><p><a href="/books/n/gene/ebj/"><b>Junctional EB</b></a>
<b>(JEB)</b> is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers, and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. The broad classification of JEB is divided into generalized and localized major subtypes with subordinate phenotypic subtypes. JEB, generalized includes: JEB, generalized severe (JEB-gen sev, formerly Herlitz JEB); JEB, generalized intermediate (JEB-gen intermed); JEB with pyloric atresia (JEB-PA); JEB-late onset (JEB-LO); and JEB with respiratory and renal involvement (JEB-RR).</p><ul><li class="half_rhythm"><div>In JEB-gen sev, the classic severe form of JEB, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur.</div></li><li class="half_rhythm"><div>In JEB-gen intermed, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be milder with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period.</div></li></ul><p>Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, and joint contractures. Biallelic pathogenic variants in one of the following four genes are known to cause JEB: <i>LAMB3</i> (70% of all JEB), <i>COL17A1</i> (12%), <i>LAMC2</i> (9%), and <i>LAMA3</i> (9%).</p><p>JEB with pyloric atresia has been associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either &#x003b1;6&#x003b2;4 integrin or plectin; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/ebd/"><b>Dystrophic EB</b></a>
<b>(DEB).</b> The blister forms below the basement membrane, in the superficial dermis. The basement membrane is attached to the blister roof, resulting in scarring when blisters heal. Pathogenic variants in <i>COL7A1</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding type VII collagen, have been demonstrated in all forms of DEB, both dominant and recessive [<a class="bk_pop" href="#eb-pa.REF.varki.2007.181">Varki et al 2007</a>].</p></div><div id="eb-pa.Management"><h2 id="_eb-pa_Management_">Management</h2><div id="eb-pa.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with epidermolysis bullosa with pyloric atresia (EB-PA), the following evaluations are recommended, if they were not performed as part of the evaluation that led to the diagnosis:</p><ul><li class="half_rhythm"><div>Evaluation of the sites of blister formation including skin and oral mucosa</div></li><li class="half_rhythm"><div>Tests of renal function including BUN, creatinine, and urinalysis</div></li><li class="half_rhythm"><div>Renal ultrasound</div></li><li class="half_rhythm"><div>Delineation of involvement of the whole esophagus (with concentration on the upper cervical portion) by barium swallow as needed. Endoscopy can be traumatic and should be avoided if possible.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="eb-pa.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Skin.</b> New blisters should be lanced and drained to prevent further spread from fluid pressure.</p><p>In most cases, dressings for blisters involve three layers:</p><ul><li class="half_rhythm"><div>A primary nonadherent dressing that does not strip the top layers of the epidermis. Tolerance to different primary layers varies. Primary layers include the following:</div><ul><li class="half_rhythm"><div>Dressings impregnated with an emollient such as petrolatum or topical antiseptic (e.g., Vaseline<sup>&#x000ae;</sup> gauze, Adaptic<sup>&#x000ae;</sup>, Xeroform<sup>&#x000ae;</sup>)</div></li><li class="half_rhythm"><div>Nonstick products (e.g., Telfa<sup>&#x000ae;</sup>, N-terface<sup>&#x000ae;</sup>)</div></li><li class="half_rhythm"><div>Silicone-based products without adhesive (e.g., Mepitel<sup>&#x000ae;</sup>, Mepilex<sup>&#x000ae;</sup>)</div></li><li class="half_rhythm"><div>Addition of a topical antibiotic or antiseptic such as bacitracin, mupirocin, silver, or honey</div></li></ul></li><li class="half_rhythm"><div>A secondary layer that provides stability for the primary layer and adds padding to allow more activity. Rolls of gauze (e.g., Kerlix<sup>&#x000ae;</sup> or Conform<sup>&#x000ae;</sup>) are commonly used.</div></li><li class="half_rhythm"><div>A tertiary layer that usually has some elastic properties and ensures the integrity of the dressing (e.g., Coban<sup>&#x000ae;</sup> or elasticized tube gauze of varying diameters such as Band Net<sup>&#x000ae;</sup> or Tubifast<sup>&#x000ae;</sup>).</div></li></ul><p><b>Gastrointestinal</b></p><ul><li class="half_rhythm"><div>Surgical intervention is required to correct pyloric atresia. Many children need medical treatment for gastroesophageal reflux disease.</div></li><li class="half_rhythm"><div>Esophageal strictures and webs can be dilated repeatedly to improve swallowing [<a class="bk_pop" href="#eb-pa.REF.azizkhan.2007.801">Azizkhan et al 2007</a>].</div></li><li class="half_rhythm"><div>Consultation with a dietitian or nutritionist can be helpful, especially if there is significant mucosal blistering in the mouth preventing adequate oral intake.</div></li></ul><p><b>Renal.</b> The following are appropriate:</p><ul><li class="half_rhythm"><div>Referral to an urologist if there are symptoms of difficulty or discomfort with voiding</div></li><li class="half_rhythm"><div>Referral to a nephrologist if renal function studies and/or urinalysis are abnormal</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>A hoarse cry in an infant should alert the clinician to the possibility of airway obstruction with granulation tissue [<a class="bk_pop" href="#eb-pa.REF.ida.2012.657">Ida et al 2012</a>]. Decisions about tracheostomy should involve the family and take into consideration the medical condition of the infant. Because of the poor prognosis and severe pain and discomfort experienced by these infants, a discussion with the family and hospital ethics committee often helps to determine the type of intervention and comfort care to provide [<a class="bk_pop" href="#eb-pa.REF.yan.2007.307">Yan et al 2007</a>].</div></li><li class="half_rhythm"><div>Some children have delays or difficulty walking because of blistering and hyperkeratosis. Appropriate footwear and physical therapy are essential to preserve ambulation.</div></li><li class="half_rhythm"><div>Psychosocial support, including social services and psychological counseling, is essential [<a class="bk_pop" href="#eb-pa.REF.lucky.2007.809">Lucky et al 2007</a>].</div></li></ul></div><div id="eb-pa.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>New blister formation can be minimized by wrapping and padding of extremities; use of soft and properly fitted clothing and footwear; and avoidance of: contact with adhesives, contact sports, and other activities that create friction.</p></div><div id="eb-pa.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>The most common secondary complication is infection. In addition to wound care, treatment of chronic infection of wounds is a challenge. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals become infected with resistant bacteria, most often methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), multidrug resistant <i>Pseudomonas aeruginosa,</i> and Group A beta-hemolytic <i>Streptococci</i>. Both antibiotics and antiseptics need to be employed.</p><p>Fluid and electrolyte problems, which can be significant and even life threatening in the neonatal period and in infants with widespread disease, require careful management.</p><p>Dilated cardiomyopathy can occur in individuals who survive the neonatal period. The development of dilated cardiomyopathy was associated with nutritional deficiency of carnitine in one study, and it has been postulated that nutritional deficiency of selenium may also contribute [<a class="bk_pop" href="#eb-pa.REF.sidwell.2000.59">Sidwell et al 2000</a>].</p><p>In children who survive the newborn period, nutritional deficiencies must also be addressed when they are identified:</p><ul><li class="half_rhythm"><div>Calcium and vitamin D replacement for osteopenia and osteoporosis</div></li><li class="half_rhythm"><div>Zinc supplementation for wound healing [<a class="bk_pop" href="#eb-pa.REF.mellerio.2007.795">Mellerio et al 2007</a>]</div></li><li class="half_rhythm"><div>Selenium and carnitine replacement for possible prevention of dilated cardiomyopathy</div></li></ul><p>Iron deficiency anemia, a chronic problem, can be treated with oral or intravenous iron infusions and red blood cell transfusions.</p></div><div id="eb-pa.Surveillance"><h3>Surveillance</h3><p>Perform annual screening for iron deficiency anemia with complete blood counts and possibly measurement of serum iron concentration to provide iron supplementation when necessary.</p><p>Screen annually for zinc deficiency by measuring serum zinc concentration to provide zinc supplementation when necessary for enhanced wound healing.</p><p>Periodic echocardiographic screening to evaluate for the development of dilated cardiomyopathy is appropriate.</p><p>Screening with bone mineral density scanning may detect early osteopenia and/ or osteoporosis. No guidelines have been established regarding the age at which this should begin.</p></div><div id="eb-pa.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Most persons with EB-PA cannot use ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>.</p><p>Poorly fitting or coarse-textured clothing and footwear should be avoided as they can cause trauma.</p><p>In general, activities that traumatize the skin (e.g., hiking, mountain biking, contact sports) should be avoided; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who are determined to participate in such activities should be encouraged to find creative ways to protect their skin.</p></div><div id="eb-pa.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#eb-pa.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="eb-pa.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Cesarean section is recommended by some obstetricians to reduce trauma to the skin of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus during delivery.</p></div><div id="eb-pa.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>See <a href="/books/n/gene/ebj/#ebj.Therapies_Under_Investigation">Junctional Epidermolysis Bullosa: Management, Therapies Under Investigation</a>.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="eb-pa.Genetic_Counseling"><h2 id="_eb-pa_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="eb-pa.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Epidermolysis bullosa with pyloric atresia (EB-PA) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>To date, there is no evidence to indicate that a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ITGA6</i>, <i>ITGB4</i>, or <i>PLEC</i> results in EB-PA.</p></div><div id="eb-pa.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are usually obligate heterozygotes (i.e., carriers of one EB-PA-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Because <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> and uniparental isodisomy have been reported in EB-PA [<a class="bk_pop" href="#eb-pa.REF.natsuga.2010.2671">Natsuga et al 2010</a>] and <a href="/books/n/gene/ebj/">JEB</a> [<a class="bk_pop" href="#eb-pa.REF.pulkkinen.1997a.611">Pulkkinen et al 1997a</a>, <a class="bk_pop" href="#eb-pa.REF.takizawa.2000.307">Takizawa et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.cserhalmifriedman.2002.468">Cserhalmi-Friedman et al 2002</a>, <a class="bk_pop" href="#eb-pa.REF.fassihi.2005.71">Fassihi et al 2005</a>, <a class="bk_pop" href="#eb-pa.REF.natsuga.2010.2671">Natsuga et al 2010</a>], <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of parents needs to be confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with EB-PA are obligate heterozygotes (carriers) for an <i>ITGA6</i>, <i>ITGB4</i>, or <i>PLEC</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> parents is at a 50% risk of being a carrier of an <i>ITGA6</i>, <i>ITGB4</i>, or <i>PLEC</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="eb-pa.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the EB-PA-related pathogenic variants in the family.</p><p>Sequencing of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in the unaffected reproductive partner of a known <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is possible and is expected to identify more than 99% of pathogenic variants in that gene, as large deletions or insertions are extremely rare.</p></div><div id="eb-pa.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="eb-pa.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>ITGA6</i>, <i>ITGB4</i>, or <i>PLEC</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for EB-PA are possible.</p><p><b>Ultrasound examination.</b> Occasionally pyloric atresia may be suspected because of oligohydramnios, with or without elevated concentration of alpha-fetoprotein and acetylcholinesterase, and echogenic material in the amniotic fluid [<a class="bk_pop" href="#eb-pa.REF.azarian.2006.57">Azarian et al 2006</a>]. Gastric blockage may also be observed on fetal MRI [<a class="bk_pop" href="#eb-pa.REF.maurice.2013.908">Maurice et al 2013</a>, <a class="bk_pop" href="#eb-pa.REF.merrow.2013.1656">Merrow et al 2013</a>]. Complete chorioamniotic membrane separation detected through ultrasound can also be suggestive of the diagnosis of EB-PA [<a class="bk_pop" href="#eb-pa.REF.dural.2014.495">Dural et al 2014</a>].</p></div></div><div id="eb-pa.Resources"><h2 id="_eb-pa_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>DebRA Chile</b></div><div>Francisco de Villagra 392</div><div>&#x000d1;u&#x000f1;oa Region Metropolitana </div><div>Chile</div><div><b>Phone:</b> +56 2 22286725</div><div><a href="http://www.debrachile.cl/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.debrachile.cl</a></div></li><li class="half_rhythm"><div><b>DEBRA International</b></div><div>Am Heumarkt 27/3</div><div>Vienna 1030</div><div>Austria</div><div><b>Phone:</b> +43 1 876 40 30-0</div><div><b>Fax:</b> +43 1 876 40 30-30</div><div><b>Email:</b> office@debra-international.org</div><div><a href="http://www.debra-international.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.debra-international.org</a></div></li><li class="half_rhythm"><div><b>DebRA of America, Inc. (Dystrophic Epidermolysis Bullosa Research Association)</b></div><div>16 East 41st Street</div><div>3rd Floor</div><div>New York NY 10017</div><div><b>Phone:</b> 866-332-7276 (toll-free); 212-868-1573</div><div><b>Email:</b> staff@debra.org</div><div><a href="http://www.debra.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.debra.org</a></div></li><li class="half_rhythm"><div><b>DebRA UK</b></div><div>DebRA House</div><div>13 Wellington Business Park</div><div>Crowthorne Berkshire RG45 6LS</div><div>United Kingdom</div><div><b>Phone:</b> +44 01344 771961</div><div><b>Fax:</b> +44 01344 762661 </div><div><b>Email:</b> debra@debra.org.uk</div><div><a href="http://www.debra.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.debra.org.uk</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001457.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epidermolysis bullosa</a></div></li><li class="half_rhythm"><div><b>EBCare Registry</b></div><div><i>The EBCare Registry is a resource for individuals and families <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by all forms of epidermolysis bullosa (EB) and qualified researchers working on approved EB research projects.</i></div><div><b>Phone:</b> 866-332-7276</div><div><b>Fax:</b> 888-363-0790</div><div><b>Email:</b> coordinator@EBCare.org</div><div><a href="http://ebcare.patientcrossroads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ebcare.patientcrossroads.org</a></div></li></ul></div><div id="eb-pa.Molecular_Genetics"><h2 id="_eb-pa_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="eb-pa.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Epidermolysis Bullosa with Pyloric Atresia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1157/table/eb-pa.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eb-pa.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_eb-pa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_eb-pa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_eb-pa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_eb-pa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_eb-pa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_eb-pa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_eb-pa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3655" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ITGA6</i></a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3655" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P23229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Integrin alpha-6</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ITGA6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGA6 database</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ITGA6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGA6</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ITGA6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGA6</a></td></tr><tr><td headers="hd_b_eb-pa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3691" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ITGB4</i></a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3691" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q25<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P16144" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Integrin beta-4</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ITGB4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGB4 database</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ITGB4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGB4</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ITGB4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ITGB4</a></td></tr><tr><td headers="hd_b_eb-pa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5339" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PLEC</i></a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5339" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15149" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Plectin</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/PLEC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PLEC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC</a></td><td headers="hd_b_eb-pa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PLEC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="eb-pa.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="eb-pa.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Epidermolysis Bullosa with Pyloric Atresia (<a href="/omim/147556,147557,226730,601282" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1157/table/eb-pa.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eb-pa.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147556" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147556</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTEGRIN, ALPHA-6; ITGA6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147557</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTEGRIN, BETA-4; ITGB4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/226730" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">226730</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601282" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601282</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PLECTIN; PLEC</td></tr></tbody></table></div></div><div id="eb-pa.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Integrins associate in pairs containing one alpha and one beta chain. The &#x003b1;6&#x003b2;4 integrin comprises one &#x003b1;6 (encoded by <i>ITGA6</i>) and one &#x003b2;4 integrin (encoded by <i>ITGB4</i>) from the integrin family of proteins, and is a component of the hemidesmosomes of the epidermis. Plectin is a large cytolinker protein expressed in the epidermis, muscle, and other tissues. Together, along with collagen XVII and CD151 (which are transmembrane proteins) and BP230, plectin and &#x003b1;6&#x003b2;4 integrin are critical structural components of the hemidesmosomes in the epidermis. The &#x003b1;6&#x003b2;4 integrin and plectin associate, causing a conformational change to a stable complex. This stabilization is thought to cause the recruitment of the other proteins into the hemidesmosomes. The &#x003b1;6&#x003b2;4 integrin also binds laminin 332 located in the basement membrane lamina lucida, and plectin binds the cytokeratins (as well as BP230), forming a continuous network of proteins that anchor the basement membrane complex to the cytokeratin layers of the epidermis. The result is a structurally resilient network of proteins binding the layers of the epidermis together [<a class="bk_pop" href="#eb-pa.REF.chung.2004.32287">Chung et al 2004</a>, <a class="bk_pop" href="#eb-pa.REF.guo.2006.489">Guo et al 2006</a>, <a class="bk_pop" href="#eb-pa.REF.yoon.2006.2732">Yoon et al 2006</a>, <a class="bk_pop" href="#eb-pa.REF.folgiero.2007.1645">Folgiero et al 2007</a>, <a class="bk_pop" href="#eb-pa.REF.de_pereda.2009.1180">de Pereda et al 2009</a>].</p><div id="eb-pa.ITGA6"><h4><i>ITGA6</i></h4><p><b>Gene structure.</b> Two transcript variants encoding two different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> have been reported. The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> of variant 1 comprises 5680 bp with an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 3273 nucleotides encoding 1091 amino acids in 26 exons. Transcript variant 2 contains an alternate coding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> from variant 1 that results in a frameshift and is encoded in a 5810-bp cDNA. The resulting protein isoform b is shorter (1073 amino acids) than isoform a and has a distinct C terminus. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1157/#eb-pa.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Only six individuals with EB-PA caused by &#x003b1;6 integrin pathogenic variants have been described in the literature. Insertion/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, splice junction, and amino acid substitution variants have been described [<a class="bk_pop" href="#eb-pa.REF.ruzzi.1997.2826">Ruzzi et al 1997</a>, <a class="bk_pop" href="#eb-pa.REF.gache.1998.914">Gache et al 1998</a>, <a class="bk_pop" href="#eb-pa.REF.l_pinard.2000.70">L&#x000e9;pinard et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>, <a class="bk_pop" href="#eb-pa.REF.masunaga.2017.160">Masunaga et al 2017</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ITGA6</i> encodes integrin-&#x003b1;6, the alpha chain of &#x003b1;6&#x003b2;4 integrin.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss or reduction of integrin-&#x003b1;6 results in disease.</p></div><div id="eb-pa.ITGB4"><h4><i>ITGB4</i></h4><p><b>Gene structure.</b> The normal full-length <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> is encoded in 41 exons spanning 36 kb of the <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The cDNA comprises 5921 bp with an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 5258 nucleotides encoding 1822 amino acids. Two <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants express different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of the protein [<a class="bk_pop" href="#eb-pa.REF.pulkkinen.1997c.823">Pulkkinen et al 1997c</a>]. The most common epidermal variant does not express <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 33. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1157/#eb-pa.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 100 pathogenic variants spanning all of <i>ITGB4</i> have been described in EB-PA [<a class="bk_pop" href="#eb-pa.REF.pulkkinen.1997b.669">Pulkkinen et al 1997b</a>, <a class="bk_pop" href="#eb-pa.REF.pulkkinen.1997c.823">Pulkkinen et al 1997c</a>, <a class="bk_pop" href="#eb-pa.REF.pulkkinen.1998a.935">Pulkkinen et al 1998a</a>, <a class="bk_pop" href="#eb-pa.REF.pulkkinen.1998b.1376">Pulkkinen et al 1998b</a>, <a class="bk_pop" href="#eb-pa.REF.ashton.2001.408">Ashton et al 2001</a>, <a class="bk_pop" href="#eb-pa.REF.nakano.2001.618">Nakano et al 2001</a>, <a class="bk_pop" href="#eb-pa.REF.iacovacci.2003.716">Iacovacci et al 2003</a>, <a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>]. Pathogenic variants that cause premature termination codons on both alleles result in the most severe phenotypes, which are frequently lethal in the neonatal period. Other types of variants including amino acid substitutions and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants may result in a less severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#eb-pa.REF.mellerio.1998.862">Mellerio et al 1998</a>, <a class="bk_pop" href="#eb-pa.REF.pulkkinen.1998b.1376">Pulkkinen et al 1998b</a>, <a class="bk_pop" href="#eb-pa.REF.chavanas.1999.2097">Chavanas et al 1999</a>, <a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>]. Rarely, <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> variants associated with severe blistering without pyloric atresia have been described [<a class="bk_pop" href="#eb-pa.REF.inoue.2000.1061">Inoue et al 2000</a>, <a class="bk_pop" href="#eb-pa.REF.jonkman.2000.227">Jonkman et al 2000</a>]. Few recurrent pathogenic variants have been reported; however the variant p.Cys61Tyr is common in Hispanic persons with JEB-PA in the United States [<a class="bk_pop" href="#eb-pa.REF.varki.2006.641">Varki et al 2006</a>]. Large deletions have also been described [<a class="bk_pop" href="#eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al 2016</a>].</p><div id="eb-pa.T.selected_itgb4_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>ITGB4</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1157/table/eb-pa.T.selected_itgb4_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__eb-pa.T.selected_itgb4_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.182G&#x0003e;A</td><td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys61Tyr</td><td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000213.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000213<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?val=NP_000204.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000204<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ITGB4</i> encodes integrin-&#x003b2;4, the alpha chain of &#x003b1;6&#x003b2;4 integrin.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss or reduction of integrin-&#x003b2;4 results in disease.</p></div><div id="eb-pa.PLEC"><h4><i>PLEC</i></h4><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> of variant 1 is 14755 bp with an <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> of 13722 nucleotides encoding 4575 amino acids in 32 exons [<a class="bk_pop" href="#eb-pa.REF.mclean.1996.1724">McLean et al 1996</a>]. Expression of the different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> results from alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 as well as use of different 5' untranslated regions. At least ten other variant transcripts have been described. The expression of different 5' regions affects the subcellular localization of the protein and the resulting attachments to organelles and intermediate filaments [<a class="bk_pop" href="#eb-pa.REF.rezniczek.2003.3181">Rezniczek et al 2003</a>]. There is also a rodless form lacking exon 31. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1157/#eb-pa.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All types of plectin variants causing EB-PA have been described: <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, insertions, and deletions [<a class="bk_pop" href="#eb-pa.REF.schara.2004.218">Schara et al 2004</a>, <a class="bk_pop" href="#eb-pa.REF.nakamura.2005.28">Nakamura et al 2005</a>, <a class="bk_pop" href="#eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</a>, <a class="bk_pop" href="#eb-pa.REF.uitto.2007.1995">Uitto et al 2007</a>]. These variants have an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance pattern and have been found throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, although clustering in the last two large exons has been observed. The mildest phenotypes are usually associated with amino acid substitutions or <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> insertions or deletions [<a class="bk_pop" href="#eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Plectin links the intermediate filament network to the hemidesmosome and desmosomes (see <a href="#eb-pa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>). At least 11 different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are produced by alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and use of different 5' untranslated regions [<a class="bk_pop" href="#eb-pa.REF.rezniczek.2003.3181">Rezniczek et al 2003</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss or reduction of plectin results in disease.</p></div></div></div><div id="eb-pa.References"><h2 id="_eb-pa_References_">References</h2><div id="eb-pa.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.ashton.2001.408">Ashton GH, Sorelli P, Mellerio JE, Keane FM, Eady RA, McGrath JA. Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">Br J Dermatol. </span>2001;<span class="ref-vol">144</span>:408–14.</span> [<a href="/pubmed/11251584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11251584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.azarian.2006.57">Azarian M, Dreux S, Vuillard E, Meneguzzi G, Haber S, Guimiot F, Muller F. Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review. <span><span class="ref-journal">Prenat Diagn. </span>2006;<span class="ref-vol">26</span>:57–9.</span> [<a href="/pubmed/16378325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16378325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.azizkhan.2007.801">Azizkhan RG, Denyer JE, Mellerio JE, Gonzalez R, Bacigalupo M, Kantor A, Passalacqua G, Palisson F, Lucky AW. Surgical management of epidermolysis bullosa: Proceedings of the Second International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. <span><span class="ref-journal">Int J Dermatol. </span>2007;<span class="ref-vol">46</span>:801–8.</span> [<a href="/pubmed/17651160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17651160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.birnbaum.2008.1063">Birnbaum RY, Landau D, Elbedour K, Ofir R, Birk OS, Carmi R. Deletion of the first pair of fibronectin type III repeats of the integrin beta-4 gene is associated with epidermolysis bullosa, pyloric atresia and aplasia cutis congenita in the original Carmi syndrome patients. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1063–6.</span> [<a href="/pubmed/18348258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18348258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.charlesworth.2003.1344">Charlesworth A, Gagnoux-Palacios L, Bonduelle M, Ortonne JP, De Raeve L, Meneguzzi G. Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin. <span><span class="ref-journal">J Invest Dermatol. </span>2003;<span class="ref-vol">121</span>:1344–8.</span> [<a href="/pubmed/14675180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14675180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.chavanas.1999.2097">Chavanas S, Gache Y, Vailly J, Kanitakis J, Pulkkinen L, Uitto J, Ortonne J, Meneguzzi G. Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:2097–105.</span> [<a href="/pubmed/10484780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10484780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.chung.2004.32287">Chung J, Yoon SO, Lipscomb EA, Mercurio AM. The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:32287–93.</span> [<a href="/pubmed/15161909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15161909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.cserhalmifriedman.2002.468">Cserhalmi-Friedman PB, Anyane-Yeboa K, Christiano AM. Paternal germline mosaicism in Herlitz junctional epidermolysis bullosa. <span><span class="ref-journal">Exp Dermatol. </span>2002;<span class="ref-vol">11</span>:468–70.</span> [<a href="/pubmed/12366701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12366701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.de_pereda.2009.1180">de Pereda JM, Lillo MP, Sonnenberg A. Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. <span><span class="ref-journal">EMBO J. </span>2009;<span class="ref-vol">28</span>:1180–90.</span> [<a href="/pmc/articles/PMC2683700/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2683700</span></a>] [<a href="/pubmed/19242489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19242489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.dural.2014.495">Dural O, Acar DK, Ekiz A, Aslan H, Polat &#x00130;, Yildirim G, Gulac B, Erdemoglu Y, Cay A, Hac&#x00131;hasanoglu O. Prenatal ultrasound findings and a new ultrasonographic sign of epidermolysis bullosa with congenital pyloric atresia: a report of three cases. <span><span class="ref-journal">J Med Ultrason. </span>2014;<span class="ref-vol">41</span>:495–8.</span> [<a href="/pubmed/27278032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27278032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.fassihi.2005.71">Fassihi H, Wessagowit V, Ashton GH, Moss C, Ward R, Denyer J, Mellerio JE, McGrath JA. Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa. <span><span class="ref-journal">Clin Exp Dermatol. </span>2005;<span class="ref-vol">30</span>:71–4.</span> [<a href="/pubmed/15663509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15663509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.fine.1999">Fine JD, Bauer EA, McGuire J, Moshell A. <em>Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry</em>. Baltimore, MD: Johns Hopkins University Press; 1999.</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.fine.2014.1103">Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, Marinkovich MP, Martinez AE, McGrath JA, Mellerio JE, Moss C, Murrell DF, Shimizu H, Uitto J, Woodley D, Zambruno G. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. <span><span class="ref-journal">J Am Acad Dermatol. </span>2014;<span class="ref-vol">70</span>:1103–26.</span> [<a href="/pubmed/24690439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24690439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.folgiero.2007.1645">Folgiero V, Bachelder RE, Bon G, Sacchi A, Falcioni R, Mercurio AM. The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>:1645–52.</span> [<a href="/pubmed/17308105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17308105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.gache.1998.914">Gache Y, Romero-Graillet C, Spadafora A, L&#x000e9;pinard C, Descamps P, Bardon CB, Ortonne JP, Meneguzzi G. A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination. <span><span class="ref-journal">J Invest Dermatol. </span>1998;<span class="ref-vol">111</span>:914–6.</span> [<a href="/pubmed/9804362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9804362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.gundesli.2010.834">Gundesli H, Talim B, Korkusuz P, Balci-Hayta B, Cirak S, Akarsu NA, Topaloglu H, Dincer P. Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:834–41.</span> [<a href="/pmc/articles/PMC2997373/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2997373</span></a>] [<a href="/pubmed/21109228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21109228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.guo.2006.489">Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">126</span>:489–502.</span> [<a href="/pubmed/16901783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16901783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.iacovacci.2003.716">Iacovacci S, Cicuzza S, Odorisio T, Silvestri E, Kayserili H, Zambruno G, Puddu P, D'Alessio M. Novel and recurrent mutations in the integrin beta 4 subunit gene causing lethal junctional epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">Exp Dermatol. </span>2003;<span class="ref-vol">12</span>:716–20.</span> [<a href="/pubmed/14705814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14705814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.ida.2012.657">Ida JB, Livshitz I, Azizkhan RG, Lucky AW, Elluru RG. Upper airway complications of junctional epidermolysis bullosa. <span><span class="ref-journal">J Pediatr. </span>2012;<span class="ref-vol">160</span>:657–61.e1.</span> [<a href="/pubmed/22050875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22050875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.inoue.2000.1061">Inoue M, Tamai K, Shimizu H, Owaribe K, Nakama T, Hashimoto T, McGrath JA. A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies Non-Herlitz junctional epidermolysis bullosa without pyloric atresia? <span><span class="ref-journal">J Invest Dermatol. </span>2000;<span class="ref-vol">114</span>:1061–4.</span> [<a href="/pubmed/10792571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10792571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.jonkman.2002.1275">Jonkman MF, Pas HH, Nijenhuis M, Kloosterhuis G, Steege G. Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex. <span><span class="ref-journal">J Invest Dermatol. </span>2002;<span class="ref-vol">119</span>:1275–81.</span> [<a href="/pubmed/12485428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12485428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.jonkman.2000.227">Jonkman MF, Schuur J, Dijk F, Heeres K, de Jong MC, van der Meer JB, Yancey KB, Pas HH. Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. <span><span class="ref-journal">Arch Dermatol. </span>2000;<span class="ref-vol">136</span>:227–31.</span> [<a href="/pubmed/10677099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10677099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.kambham.2000.190">Kambham N, Tanji N, Seigle RL, Markowitz GS, Pulkkinen L, Uitto J, D'Agati VD. Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa. <span><span class="ref-journal">Am J Kidney Dis. </span>2000;<span class="ref-vol">36</span>:190–6.</span> [<a href="/pubmed/10873890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10873890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.kossharnes.2002.87">Koss-Harnes D, Hoyheim B, Anton-Lamprecht I, Gjesti A, Jorgensen RS, Jahnsen FL, Olaisen B, Wiche G, Gedde-Dahl T Jr. A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. <span><span class="ref-journal">J Invest Dermatol. </span>2002;<span class="ref-vol">118</span>:87–93.</span> [<a href="/pubmed/11851880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11851880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.kossharnes.2004.124">Koss-Harnes D, Hoyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T Jr. Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation. <span><span class="ref-journal">Acta Derm Venereol. </span>2004;<span class="ref-vol">84</span>:124–31.</span> [<a href="/pubmed/15206692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15206692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.kunz.2000.376">Kunz M, Rouan F, Pulkkinen L, Hamm H, Jeschke R, Bruckner-Tuderman L, Brocker EB, Wiche G, Uitto J, Zillikens D. Mutation reports: epidermolysis bullosa simplex associated with severe mucous membrane involvement and novel mutations in the plectin gene. <span><span class="ref-journal">J Invest Dermatol. </span>2000;<span class="ref-vol">114</span>:376–80.</span> [<a href="/pubmed/10652001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10652001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.l_pinard.2000.70">L&#x000e9;pinard C, Descamps P, Meneguzzi G, Blanchet-Bardon C, Germain DP, Larget-Piet L, Beringue F, Berchel C, Muller F, Dumez Y. Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk. <span><span class="ref-journal">Prenat Diagn. </span>2000;<span class="ref-vol">20</span>:70–5.</span> [<a href="/pubmed/10701857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10701857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.lucky.2007.809">Lucky AW, Pfendner E, Pillay E, Paskel J, Weiner M, Palisson F. Psychosocial aspects of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. <span><span class="ref-journal">Int J Dermatol. </span>2007;<span class="ref-vol">46</span>:809–14.</span> [<a href="/pubmed/17651161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17651161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.masunaga.2015.61">Masunaga T, Niizeki H, Yasuda F, Yoshida K, Amagai M, Ishiko A. Splicing abnormality of integrin &#x003b2;4 gene (ITGB4) due to nucleotide substitutions far from splice site underlies pyloric atresia-junctional epidermolysis bullosa syndrome. <span><span class="ref-journal">J Dermatol Sci. </span>2015;<span class="ref-vol">78</span>:61–6.</span> [<a href="/pubmed/25728941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25728941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.masunaga.2017.160">Masunaga T, Ogawa J, Akiyama M, Nishikawa T, Shimizu H, Ishiko A. Compound heterozygosity for novel splice site mutations of ITGA6 in lethal junctional epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">J Dermatol. </span>2017;<span class="ref-vol">44</span>:160–6.</span> [<a href="/pubmed/27607025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27607025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.maurice.2013.908">Maurice P, Eyrolle-Guignot D, Dhombres F, Garel C, Gonzales M, Muller F, Jouannic JM. The key role of ultrasound examination in the prenatal diagnosis of epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">Prenat Diagn. </span>2013;<span class="ref-vol">33</span>:908–9.</span> [<a href="/pubmed/23613220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23613220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.mclean.1996.1724">McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K, McGrath JA, McMillan JR, Eady RA, Leigh IM, Christiano AM, Uitto J. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. <span><span class="ref-journal">Genes Dev. </span>1996;<span class="ref-vol">10</span>:1724–35.</span> [<a href="/pubmed/8698233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8698233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.mellerio.1998.862">Mellerio JE, Pulkkinen L, McMillan JR, Lake BD, Horn HM, Tidman MJ, Harper JI, McGrath JA, Uitto J, Eady RA. Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease. <span><span class="ref-journal">Br J Dermatol. </span>1998;<span class="ref-vol">139</span>:862–71.</span> [<a href="/pubmed/9892956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9892956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.mellerio.2007.795">Mellerio JE, Weiner M, Denyer JE, Pillay EI, Lucky AW, Bruckner A, Palisson F. Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. <span><span class="ref-journal">Int J Dermatol. </span>2007;<span class="ref-vol">46</span>:795–800.</span> [<a href="/pubmed/17651159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17651159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a &#x000c1;, Garc&#x000ed;a M, Garc&#x000ed;a E, Llames S, Charlesworth A, de Lucas R, Vicente A, Trujillo-Tiebas MJ, Coto P, Costa M, Vera &#x000c1;, L&#x000f3;pez-Pesta&#x000f1;a A, Murillas R, Meneguzzi G, Jorcano JL, Conti CJ, Esc&#x000e1;mez Toledano MJ, del R&#x000ed;o Nechaevsky M. Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">Exp Dermatol. </span>2016;<span class="ref-vol">25</span>:269–74.</span> [<a href="/pubmed/26739954" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26739954</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.merrow.2013.1656">Merrow AC, Frischer JS, Lucky AW. Pyloric atresia with epidermolysis bullosa: fetal MRI diagnosis with postnatal correlation. <span><span class="ref-journal">Pediatr Radiol. </span>2013;<span class="ref-vol">43</span>:1656–61.</span> [<a href="/pubmed/23832020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23832020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.mutlu.2015.385">Mutlu M, Kalay E, Dilber B, Aslan Y, Dilber E, Almaani N, McGrath JA. Pyloric atresia-junctional epidermolysis bullosa syndrome showing novel c.4505-4508insACTC mutations in integrin b4 gene (ITGB4). <span><span class="ref-journal">Turk J Pediatr. </span>2015;<span class="ref-vol">57</span>:385–7.</span> [<a href="/pubmed/27186702" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27186702</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.nakamura.2005.28">Nakamura H, Sawamura D, Goto M, Nakamura H, McMillan JR, Park S, Kono S, Hasegawa S, Paku S, Nakamura T, Ogiso Y, Shimizu H. Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC). <span><span class="ref-journal">J Mol Diagn. </span>2005;<span class="ref-vol">7</span>:28–35.</span> [<a href="/pmc/articles/PMC1867514/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1867514</span></a>] [<a href="/pubmed/15681471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15681471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.nakano.2001.618">Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky AW, Garzon M, Stevens CA, Robertson S, Pfendner E, Uitto J. Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype correlations. <span><span class="ref-journal">Pediatr Res. </span>2001;<span class="ref-vol">49</span>:618–26.</span> [<a href="/pubmed/11328943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11328943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.nakano.2000.493">Nakano A, Pfendner E, Hashimoto I, Uitto J. Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. <span><span class="ref-journal">J Invest Dermatol. </span>2000;<span class="ref-vol">115</span>:493–8.</span> [<a href="/pubmed/11023379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11023379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.natsuga.2010.2671">Natsuga K, Nishie W, Arita K, Shinkuma S, Nakamura H, Kubota S, Imakado S, Akiyama M, Shimizu H. Complete paternal isodisomy of chromosome 17 in junctional epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">J Invest Dermatol. </span>2010;<span class="ref-vol">130</span>:2671–4.</span> [<a href="/pubmed/20596088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20596088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pasmooij.2004.669">Pasmooij AM, van der Steege G, Pas HH, Smitt JH, Nijenhuis AM, Zuiderveen J, Jonkman MF. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen. <span><span class="ref-journal">Br J Dermatol. </span>2004;<span class="ref-vol">151</span>:669–74.</span> [<a href="/pubmed/15377356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15377356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pfendner.2005.241">Pfendner E, Rouan F, Uitto J. Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations. <span><span class="ref-journal">Exp Dermatol. </span>2005;<span class="ref-vol">14</span>:241–9.</span> [<a href="/pubmed/15810881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15810881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pfendner.2007.781">Pfendner EG, Bruckner A, Conget P, Mellerio J, Palisson F, Lucky AW. Basic science of epidermolysis bullosa and diagnostic and molecular characterization: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. <span><span class="ref-journal">Int J Dermatol. </span>2007;<span class="ref-vol">46</span>:781–94.</span> [<a href="/pubmed/17651158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17651158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pulkkinen.1998a.935">Pulkkinen L, Bruckner-Tuderman L, August C, Uitto J. Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the beta4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">Am J Pathol. </span>1998a;<span class="ref-vol">152</span>:935–41.</span> [<a href="/pmc/articles/PMC1858243/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1858243</span></a>] [<a href="/pubmed/9546354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9546354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pulkkinen.1997a.611">Pulkkinen L, Bullrich F, Czarnecki P, Weiss L, Uitto J. Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa. <span><span class="ref-journal">Am J Hum Genet. </span>1997a;<span class="ref-vol">61</span>:611–9.</span> [<a href="/pmc/articles/PMC1715967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715967</span></a>] [<a href="/pubmed/9326326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326326</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pulkkinen.1997b.669">Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. <span><span class="ref-journal">Hum Mol Genet. </span>1997b;<span class="ref-vol">6</span>:669–74.</span> [<a href="/pubmed/9158140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9158140</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pulkkinen.1997c.823">Pulkkinen L, Kurtz K, Xu Y, Bruckner-Tuderman L, Uitto J. Genomic organization of the integrin beta 4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. <span><span class="ref-journal">Lab Invest. </span>1997c;<span class="ref-vol">76</span>:823–33.</span> [<a href="/pubmed/9194858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9194858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.pulkkinen.1998b.1376">Pulkkinen L, Rouan F, Bruckner-Tuderman L, Wallerstein R, Garzon M, Brown T, Smith L, Carter W, Uitto J. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. <span><span class="ref-journal">Am J Hum Genet. </span>1998b;<span class="ref-vol">63</span>:1376–87.</span> [<a href="/pmc/articles/PMC1377547/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377547</span></a>] [<a href="/pubmed/9792864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9792864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.puvabanditsin.1997.359">Puvabanditsin S, Garrow E, Samransamraujkit R, Lopez LA, Lambert WC. Epidermolysis bullosa associated with congenital localized absence of skin, fetal abdominal mass, and pyloric atresia. <span><span class="ref-journal">Pediatr Dermatol. </span>1997;<span class="ref-vol">14</span>:359–62.</span> [<a href="/pubmed/9336805" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9336805</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.rezniczek.2003.3181">Rezniczek GA, Abrahamsberg C, Fuchs P, Spazierer D, Wiche G. Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:3181–94.</span> [<a href="/pubmed/14559777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14559777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.ruzzi.1997.2826">Ruzzi L, Gagnoux-Palacios L, Pinola M, Belli S, Meneguzzi G, D'Alessio M, Zambruno G. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. <span><span class="ref-journal">J Clin Invest. </span>1997;<span class="ref-vol">99</span>:2826–31.</span> [<a href="/pmc/articles/PMC508131/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC508131</span></a>] [<a href="/pubmed/9185503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9185503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.salvestrini.2008.585">Salvestrini C, McGrath JA, Ozoemena L, Husain K, Buhamrah E, Sabery N, Leichtner A, Rufo PA, Perez-Atayde A, Orteu CH, Torrente F, Heuschkel RB, Thomson MA, Murch SH. Desquamative enteropathy and pyloric atresia without skin disease caused by a novel intracellular beta4 integrin mutation. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2008;<span class="ref-vol">47</span>:585–91.</span> [<a href="/pubmed/18955862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.schara.2004.218">Schara U, Tucke J, Mortier W, Nusslein T, Rouan F, Pfendner E, Zillikens D, Bruckner-Tuderman L, Uitto J, Wiche G, Schroder R. Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation. <span><span class="ref-journal">Eur J Pediatr. </span>2004;<span class="ref-vol">163</span>:218–22.</span> [<a href="/pubmed/14963703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14963703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.sidwell.2000.59">Sidwell RU, Yates R, Atherton D. Dilated cardiomyopathy in dystrophic epidermolysis bullosa. <span><span class="ref-journal">Arch Dis Child. </span>2000;<span class="ref-vol">83</span>:59–63.</span> [<a href="/pmc/articles/PMC1718386/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1718386</span></a>] [<a href="/pubmed/10869001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10869001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.takizawa.2000.307">Takizawa Y, Pulkkinen L, Chao SC, Nakajima H, Nakano Y, Shimizu H, Uitto J. Mutation report: complete paternal uniparental isodisomy of chromosome 1: a novel mechanism for Herlitz junctional epidermolysis bullosa. <span><span class="ref-journal">J Invest Dermatol. </span>2000;<span class="ref-vol">115</span>:307–11.</span> [<a href="/pubmed/10951251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10951251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.uitto.2007.1995">Uitto J, Richard G, McGrath JA. Diseases of epidermal keratins and their linker proteins. <span><span class="ref-journal">Exp Cell Res. </span>2007;<span class="ref-vol">313</span>:1995–2009.</span> [<a href="/pmc/articles/PMC2578874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2578874</span></a>] [<a href="/pubmed/17531221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17531221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.varki.2006.641">Varki R, Sadowski S, Pfendner E, Uitto J. Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:641–52.</span> [<a href="/pmc/articles/PMC2564586/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564586</span></a>] [<a href="/pubmed/16473856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16473856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.varki.2007.181">Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:181–92.</span> [<a href="/pmc/articles/PMC2598021/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598021</span></a>] [<a href="/pubmed/16971478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16971478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.villa.2015.165">Villa CR, Ryan TD, Collins JJ, Taylor MD, Lucky AW, Jefferies JL. Left ventricular non-compaction cardiomyopathy associated with epidermolysis bullosa simplex with muscular dystrophy and PLEC mutation. <span><span class="ref-journal">Neuromuscul Disord. </span>2015;<span class="ref-vol">25</span>:165–8.</span> [<a href="/pubmed/25454730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25454730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.walker.2017.e61">Walker GD, Woody M, Orrin E, Mellerio JE, Levy ML. Epidermolysis bullosa with pyloric atresia and significant urologic involvement. <span><span class="ref-journal">Pediatr Dermatol. </span>2017;<span class="ref-vol">34</span>:e61–e64.</span> [<a href="/pubmed/27813154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27813154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.wallerstein.2000.286">Wallerstein R, Klein ML, Genieser N, Pulkkinen L, Uitto J. Epidermolysis bullosa, pyloric atresia, and obstructive uropathy: a report of two case reports with molecular correlation and clinical management. <span><span class="ref-journal">Pediatr Dermatol. </span>2000;<span class="ref-vol">17</span>:286–9.</span> [<a href="/pubmed/10990577" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10990577</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.yan.2007.307">Yan EG, Paris JJ, Ahluwalia J, Lane AT, Bruckner AL. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa. <span><span class="ref-journal">J Perinatol. </span>2007;<span class="ref-vol">27</span>:307–11.</span> [<a href="/pubmed/17363907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17363907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="eb-pa.REF.yoon.2006.2732">Yoon SO, Shin S, Lipscomb EA. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:2732–9.</span> [<a href="/pubmed/16510594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16510594</span></a>]</div></li></ul></div></div><div id="eb-pa.Chapter_Notes"><h2 id="_eb-pa_Chapter_Notes_">Chapter Notes</h2><div id="eb-pa.Author_Notes"><h3>Author Notes</h3><p>Web: <a href="http://www.genedx.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.genedx.com</a></p><p>Web: <a href="http://www.cincinnatichildrens.org/eb-center" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cincinnatichildrens.org/eb-center</a></p></div><div id="eb-pa.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 September 2017 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 February 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 April 2009 (cd) Revision: <i>PLEC</i> testing clinically available; prenatal testing available</div></li><li class="half_rhythm"><div>22 February 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>10 May 2007 (egp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1157</span><span class="label">PMID: <a href="/pubmed/20301336" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301336</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ebs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gale-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1157&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1157/?report=reader">PubReader</a></li><li><a href="/books/NBK1157/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1157" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1157" style="display:none" title="Cite this Page"><div class="bk_tt">Pfendner EG, Lucky AW. Epidermolysis Bullosa with Pyloric Atresia. 2008 Feb 22 [Updated 2017 Sep 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1157/pdf/Bookshelf_NBK1157.pdf">PDF version of this page</a> (537K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#eb-pa.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#eb-pa.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#eb-pa.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#eb-pa.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#eb-pa.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#eb-pa.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#eb-pa.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#eb-pa.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#eb-pa.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#eb-pa.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#eb-pa.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5339[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PLEC</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3691[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ITGB4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3655[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ITGA6</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1157+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1486810" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1486810" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1486810" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1486810" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301304" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Junctional Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Junctional Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301481" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophic Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301543" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Epidermolysis Bullosa Simplex<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Bruckner AL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24027798" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Erwin A, Balwani M, Desnick RJ, Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301336" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301336" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412b039a66ee2babb6ae3">Epidermolysis Bullosa with Pyloric Atresia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Epidermolysis Bullosa with Pyloric Atresia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:53:52-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D429EE04110610000000000B1004A&amp;ncbi_session=CE8D429EE0412AF1_0177SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1157%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1157&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1157/&amp;ncbi_pagename=Epidermolysis Bullosa with Pyloric Atresia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D429EE0412AF1_0177SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>